These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 23899066)
21. Utility of TTF-1 and Napsin-A in the work-up of malignant effusions. El Hag M; Schmidt L; Roh M; Michael CW Diagn Cytopathol; 2016 Apr; 44(4):299-304. PubMed ID: 26799356 [TBL] [Abstract][Full Text] [Related]
22. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468 [TBL] [Abstract][Full Text] [Related]
23. IMP3, NESP55, TTF-1 and CDX2 serve as an immunohistochemical panel in the distinction among small-cell carcinoma, gastrointestinal carcinoid, and pancreatic endocrine tumor metastasized to the liver. Denby KS; Briones AJ; Bourne PA; Spaulding BO; Lu D; Fischer-Colbrie R; Qu Z; Wang HL; Xu H Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):573-9. PubMed ID: 22495359 [TBL] [Abstract][Full Text] [Related]
24. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray. Turner BM; Cagle PT; Sainz IM; Fukuoka J; Shen SS; Jagirdar J Arch Pathol Lab Med; 2012 Feb; 136(2):163-71. PubMed ID: 22288963 [TBL] [Abstract][Full Text] [Related]
25. Unusual expression of thyroid transcription factor 1 and napsin A in metastatic adenoid cystic carcinoma of extrapulmonary origin in the lung. An J; Park S; Sung SH; Cho MS; Kim SC Am J Clin Pathol; 2014 May; 141(5):712-7. PubMed ID: 24713744 [TBL] [Abstract][Full Text] [Related]
26. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions. Dejmek A; Naucler P; Smedjeback A; Kato H; Maeda M; Yashima K; Maeda J; Hirano T Diagn Cytopathol; 2007 Aug; 35(8):493-7. PubMed ID: 17636482 [TBL] [Abstract][Full Text] [Related]
27. CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall. Mazziotta RM; Borczuk AC; Powell CA; Mansukhani M Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):55-60. PubMed ID: 15722794 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases. Srodon M; Westra WH Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164 [TBL] [Abstract][Full Text] [Related]
29. The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment. Ma Y; Fan M; Dai L; Kang X; Liu Y; Sun Y; Yan W; Liang Z; Xiong H; Chen K Tumour Biol; 2015 Sep; 36(10):8085-92. PubMed ID: 25982999 [TBL] [Abstract][Full Text] [Related]
30. The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas. El-Maqsoud NM; Tawfiek ER; Abdelmeged A; Rahman MF; Moustafa AA Tumour Biol; 2016 Mar; 37(3):3123-34. PubMed ID: 26427663 [TBL] [Abstract][Full Text] [Related]
31. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases. Zamecnik J; Kodet R Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814 [TBL] [Abstract][Full Text] [Related]
32. IMP3 can predict aggressive behaviour of lung adenocarcinoma. Beljan Perak R; Durdov MG; Capkun V; Ivcevic V; Pavlovic A; Soljic V; Peric M Diagn Pathol; 2012 Nov; 7():165. PubMed ID: 23190601 [TBL] [Abstract][Full Text] [Related]
33. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Mukhopadhyay S; Katzenstein AL Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283 [TBL] [Abstract][Full Text] [Related]
34. Napsin A is differentially expressed in sclerosing hemangiomas of the lung. Schmidt LA; Myers JL; McHugh JB Arch Pathol Lab Med; 2012 Dec; 136(12):1580-4. PubMed ID: 23194051 [TBL] [Abstract][Full Text] [Related]
35. TTF-1 and surfactant-B as co-adjuvants in the diagnosis of lung adenocarcinoma and pleural mesothelioma. Bakir K; Koçer NE; Deniz H; Güldür ME Ann Diagn Pathol; 2004 Dec; 8(6):337-41. PubMed ID: 15614737 [TBL] [Abstract][Full Text] [Related]
36. Unexpected TTF-1 Positivity in a Subset of Gastric Adenocarcinomas. Choi SM; Furth EE; Zhang PJ Appl Immunohistochem Mol Morphol; 2016 Sep; 24(8):603-7. PubMed ID: 26469324 [TBL] [Abstract][Full Text] [Related]
37. Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids. Saqi A; Alexis D; Remotti F; Bhagat G Am J Clin Pathol; 2005 Mar; 123(3):394-404. PubMed ID: 15716236 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases. Malmros K; Lindholm A; Vidarsdottir H; Jirström K; Nodin B; Botling J; Mattsson JSM; Micke P; Planck M; Jönsson M; Staaf J; Brunnström H Virchows Arch; 2024 Aug; 485(2):347-357. PubMed ID: 37349623 [TBL] [Abstract][Full Text] [Related]
39. TTF-1, napsin A and CDX2 co-expression in metastatic rectal adenocarcinoma to the lung. Li W; Cohen MB Cytopathology; 2021 Jan; 32(1):146-148. PubMed ID: 32633432 [No Abstract] [Full Text] [Related]
40. Surfactant Protein A and Napsin A in the Immunohistochemical Characterization of Canine Pulmonary Carcinomas: Comparison With Thyroid Transcription Factor-1. Beck J; Miller MA; Frank C; DuSold D; Ramos-Vara JA Vet Pathol; 2017 Sep; 54(5):767-774. PubMed ID: 28578631 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]